The top documents tagged [increased cv risk]

Contraversies in hypertension management
Health & Medicine Contraversies in hypertension management

109 views

Niacin Use in Patients with Low HDL-Cholesterol Receiving Intensive Statin Therapy William E. Boden, MD, FACC, FAHA Jeffrey Probstfield, MD, FACC, FAHA
Documents Niacin Use in Patients with Low HDL-Cholesterol Receiving Intensive Statin Therapy William E. Boden, MD, FACC, FAHA Jeffrey Probstfield, MD, FACC, FAHA

217 views

11111 COX-2 FDA Advisory Committee Meeting 2005 Rofecoxib Speaker: Ned S. Braunstein, MD Senior Director, Merck Research Labs
Documents 11111 COX-2 FDA Advisory Committee Meeting 2005 Rofecoxib Speaker: Ned S. Braunstein, MD Senior Director, Merck Research Labs

215 views

Obesity and Dyslipidemia AR Esteghamati, MD Associate Professor of Internal Medicine Endocrinology and Metabolism Research Center Tehran University of
Documents Obesity and Dyslipidemia AR Esteghamati, MD Associate Professor of Internal Medicine Endocrinology and Metabolism Research Center Tehran University of

213 views

Evidence For A Novel Bone-Kidney Axis Regulating Systemic Phosphate Homeostasis L. Darryl Quarles, M.D. Summerfield Endowed Professor of Nephrology University
Documents Evidence For A Novel Bone-Kidney Axis Regulating Systemic Phosphate Homeostasis L. Darryl Quarles, M.D. Summerfield Endowed Professor of Nephrology University

217 views

Introduction
Documents Introduction

24 views

AIM-HIGH Trial
Documents AIM-HIGH Trial

43 views

Evidence For A Novel Bone-Kidney Axis Regulating Systemic Phosphate Homeostasis
Documents Evidence For A Novel Bone-Kidney Axis Regulating Systemic Phosphate Homeostasis

25 views

Niacin Use in Patients with Low HDL-Cholesterol Receiving Intensive Statin Therapy William E. Boden, MD, FACC, FAHA Jeffrey Probstfield, MD, FACC, FAHA
Documents Niacin Use in Patients with Low HDL-Cholesterol Receiving Intensive Statin Therapy William E. Boden, MD, FACC, FAHA Jeffrey Probstfield, MD, FACC, FAHA

219 views

De-risking the development programs of CETP inhibitors after the torcetrapib failure: Endothelial function & blood pressure Prof. John Deanfield University
Documents De-risking the development programs of CETP inhibitors after the torcetrapib failure: Endothelial function & blood pressure Prof. John Deanfield University

217 views

CAUSALITY ASSESSMENT OF SUSPECTED AEs Dr. Retesh Kumar Head, Global PhV Department 12/13/2015
Documents CAUSALITY ASSESSMENT OF SUSPECTED AEs Dr. Retesh Kumar Head, Global PhV Department 12/13/2015

212 views

ALLHAT 6/5/2006 - 1 CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Documents ALLHAT 6/5/2006 - 1 CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)

215 views